Kee-Jong Hong

Kee-Jong Hong (BS, Seoul National Univ; MS, Seoul National Univ;PhD, Texas Tech Univ) is currently a Professor at the Department ofthe Microbiology, Gachon University School of Medicine, Korea, and aProgram Manager of Division for Health Security at Korea Advanced Research Project Agencyfor Health (ARPA-H) after finishing Korean National project for the mRNA Vaccine R&D,KmVAC(Korea mRNA Vaccine Initiative). He has conducted research and development relatedto the pandemic preparedness including Influenza, Coronavirus, Ebola virus, Nipah virus andBioterrorism pathogens such as Anthrax, tularemia. He worked for the Korean Dsease Controland Prevention Agency (KCDA) for 10 years as a government officer, also worked as a directorof the industrial research institutes including the Interpark BioConvergence (currently GradientBioConvergence) and the NKmax for another 7 years before joining the Gachon University. He isserving for the Korean Vaccine Society as a chair of publication committee, also serving for theKorean Society for Zoonoses as a vice president. In 2024, he was selected as a member ofScientific Advisory Committee for CEPI (Coalition for Epidemic Preparedness Innovations) andkeeps working till 2027.